LMAN2 and breast cancer: The KM plotter and the bc-GenExMiner v4.7 databases demonstrated that elevated LMAN2 expression level was linked to the unfavorable OS, disease-free survival (DFS), and RFS in breast cancer (Figures 3(a)–3(c)).